coisa
-
-
Marea Therapeutics doses first patient in MAR002 phase 2 trial
-
Prime Medicine doses first patient in Wilson disease gene therapy trial
-
Teledyne delivers infrared sensors for U.S. missile defense
-
CAMINUS to manufacture Amprius battery cells in Indianapolis
-
FTC Solar amends credit agreement, defers $5M payment
-
Comtech appoints Christopher Maloney to board of directors
-
Ardelyx to present hyperphosphatemia research at ASN meeting
-
vTv Therapeutics completes Phase 3 enrollment for T1D drug
-
GoodLinks: Read Later and Do More with Your Articles [Sponsor]
It happens to all of us. You come across an article you want to read, but you’re in the middle of something and don’t have the time. GoodLinks gives those articles a home on your iPhone, iPad, and Mac, with a clean, customizable reading experience when you’re ready to return to them. Recently updated for…